Clinical trials
Observational Acromegaly trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Unknown status | 19 |
| Recruiting | 9 |
| Withdrawn | 4 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ipsen | 19 |
| Cedars-Sinai Medical Center | 5 |
| University of Aarhus | 5 |
| Columbia University | 3 |
| Federico II University | 3 |
| IRCCS San Raffaele | 3 |
| Massachusetts General Hospital | 3 |
| Pfizer | 3 |
| Rigshospitalet, Denmark | 3 |
| Barts & The London NHS Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 85 |
| Pituitary Neoplasms | 10 |
| Prolactinoma | 6 |
| Dwarfism, Pituitary | 4 |
| Cushing Syndrome | 3 |
| Endocrine System Diseases | 3 |
| Insulin Resistance | 3 |
| Pituitary Diseases | 3 |
| Bone Diseases | 2 |
| Gigantism | 2 |
Trials
Showing 76 to 85 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.